Holen Sie sich die Stockscreener-App
6.17
3.35%
0.20
Handel nachbörslich:
6.17
Schlusskurs vom Vortag:
$5.97
Offen:
$5.88
24-Stunden-Volumen:
69,723
Relative Volume:
0.12
Marktkapitalisierung:
$296.20M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-18.17%
1M Leistung:
-31.60%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$5.88
$6.43
1-Wochen-Bereich:
$5.69
$8.00
52-Wochen-Spanne:
$3.50
$14.30
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Company Profile
Vergleichen Sie ZYBT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZYBT
Zhengye Biotechnology Holding Ltd
|
6.17 | 296.20M | 0 | 0 | 0 | 0.00 |
|
RGC
Regencell Bioscience Holdings Ltd
|
14.60 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
159.19 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.35 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.37 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.64 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Zhengye Biotechnology Holding Ltd Aktie (ZYBT) Neueste Nachrichten
Zhengye Biotechnology (NASDAQ:ZYBT) Trading Down 6% – Time to Sell? - Defense World
Zhengye Biotechnology Receives NASDAQ Delinquency Notice for Late Filing - TipRanks
Zhengye Biotechnology faces NASDAQ compliance issue By Investing.com - Investing.com Nigeria
Zhengye Biotechnology faces NASDAQ compliance issue - Investing.com
Zhengye Biotechnology Holding Limited Receives NASDAQ Delinquency Letter for Non-Compliance with Listing Requirements - Nasdaq
Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F - GlobeNewswire
The Alternative Data Center Stocks Nobody Is Watching Right Now - Energy & Capital
Why Meta Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - Benzinga
Tesla, Regeneron Among Market Cap Stock Movers on Wednesday - Investing.com Australia
Zhengye Biotechnology Holding Ltd Inc. (ZYBT) Price Performance: A Technical Analysis Perspective - investchronicle.com
Tesla, UnitedHealth Lead Market Cap Stock Movers on Wednesday By Investing.com - Investing.com South Africa
Zhengye Biotechnology Delays 20-F Filing - TipRanks
Spotify, Regeneron lead Tuesday’s market cap stock movers By Investing.com - Investing.com South Africa
Zhengye Biotechnology Holding Ltd (ZYBT) Surges 35% - Energy & Capital
Pre-market Movers: STSS, THRD, PTN, VRAX... - RTTNews
The Only Nuclear Stocks to Buy Today - Energy & Capital
Zhengye Biotechnology Holding Ltd (ZYBT): Why Shares Soared 34.91% in a Single Day - Energy & Capital
Understanding ZYBT stock ratios for better investment decisions - uspostnews.com
Navigating ZYBT Stock: Zhengye Biotechnology Holding Ltd Journey - investchronicle.com
Chinese Fire Up Their Most Powerful Nuclear Plant - Energy & Capital
If You’re Not Buying Oil Stocks Right Now, Then You Hate Money. - Energy & Capital
Catherine De Noire Reveals Uncomfortable Truth: Prostitutes Make Excellent Financial Advisors - Energy & Capital
Gold Is The Place To Be... Or Is It? - Energy & Capital
Buy Oil NOW, Thank Me Later - Energy & Capital
Warren Buffett Was Right Again, Here’s What He’s Doing Next - Energy & Capital
A Closer Look At Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) Uninspiring ROE - simplywall.st
Should We Be Cautious About Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) ROE Of 6.9%? - Yahoo Finance
Zhengye Biotechnology Forms Joint Venture to Expand Poultry Vaccine Sales - TipRanks
Nvidia, Tesla Slide Among Mega-Cap Movers on Wednesday By Investing.com - Investing.com Canada
Pre-market Movers: OSRH, SURG, BLNE, HUMA, TNON… - RTTNews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Kuke Music Holding Ltd ADR’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com
Kroger CEO Questions Remain While the Market Moves on - Energy & Capital
This Silver Stock Is Like No Other - Energy & Capital
Trump’s Only Solution to Low Energy Prices - Energy & Capital
Trump Vs. OPEC Round 2: The Great Oil Showdown of 2025 - Energy & Capital
3 E Network Technology Group Ltd’s Quiet Period Will End on February 17th (NASDAQ:MASK) - Defense World
Zhengye Biotechnology Holding Limited’s (NASDAQ:ZYBT) Quiet Period Set To Expire on February 17th - Defense World
Data Gusher: The AI Arms Race Has Begun - Energy & Capital
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising - Bamboo Works
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option - GlobeNewswire
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option - The Manila Times
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering - GlobeNewswire
ZYBT Stock Price and Chart — NASDAQ:ZYBT - TradingView
ZYBT IPO NewsChinese animal health company Zhengye Biotechnology prices US IPO at the $4 low end - Renaissance Capital
Chinese vaccine maker Zhengye Biotechnology prices IPO at $4 per share - MSN
Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering - GlobeNewswire
Zhengye Biotechnology Holding Limited (ZYBT) to Raise $7 Million in IPO - Defense World
Finanzdaten der Zhengye Biotechnology Holding Ltd-Aktie (ZYBT)
Es liegen keine Finanzdaten für Zhengye Biotechnology Holding Ltd (ZYBT) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.05%
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):